Luis Enrique Pizarro Maqueda
Directeur/Bestuurslid bij Drugs for Neglected Diseases initiative
Profiel
Luis Enrique Pizarro Maqueda is currently the Executive Director at Drugs for Neglected Diseases initiative since 2022.
Prior to this, he worked as the Director-Internal Audit at Abengoa SA from 2005 to 2013.
He completed his undergraduate degree from the University of Seville, graduate degree from Universidad Pablo de Olavide, and MBA from Instituto de Estudios Superiores de la Empresa.
Actieve functies van Luis Enrique Pizarro Maqueda
Bedrijven | Functie | Begin |
---|---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Directeur/Bestuurslid | 05-09-2022 |
Eerdere bekende functies van Luis Enrique Pizarro Maqueda
Bedrijven | Functie | Einde |
---|---|---|
ABENGOA, S.A. | Comptroller/Controller/Auditor | - |
Opleiding van Luis Enrique Pizarro Maqueda
University of Seville | Undergraduate Degree |
Instituto de Estudios Superiores de la Empresa | Masters Business Admin |
Universidad Pablo de Olavide | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ABENGOA, S.A. | Industrial Services |
Bedrijven in privébezit | 1 |
---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |